TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.0969
+0.0008 (0.83%)
Oct 23, 2025, 1:16 PM CET
TME Pharma Market Cap
TME Pharma has a market cap or net worth of €9.01 million as of October 23, 2025. Its market cap has increased by 63.12% in one year.
Market Cap
9.01M
Enterprise Value
5.76M
Revenue
19.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.10
Market Cap Chart
Since September 30, 2016, TME Pharma's market cap has decreased from 43.13M to 9.01M, a decrease of -79.12%. That is a compound annual growth rate of -15.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 8.83M | 25.06% |
| Dec 31, 2024 | 7.06M | 478.85% |
| Dec 29, 2023 | 1.22M | -26.24% |
| Dec 30, 2022 | 1.65M | -90.52% |
| Dec 31, 2021 | 17.44M | -28.42% |
| Dec 31, 2020 | 24.37M | 221.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 143.60B |
| Sanofi | 105.52B |
| Sartorius Stedim Biotech | 20.65B |
| bioMérieux | 13.42B |
| Eurofins Scientific SE | 11.19B |
| Ipsen | 9.80B |
| ABIVAX Société Anonyme | 5.75B |
| Virbac | 3.00B |